FDA's approval of the world's first vaccine against RSV will offer a new tool in an old fight – 4 questions answered

The newly approved RSV vaccine could be rolled out by fall 2023, in time for the typical winter surge in RSV infections.

Annette Regan, Associate Professor of Epidemiology, University of San Francisco • conversation
May 10, 2023 ~7 min

Moderna's experimental cancer vaccine treats but doesn't prevent melanoma – a biochemist explains how it works

Preventive and therapeutic vaccines both train the immune system to fight disease, but they are used in different ways.

Mark R. O'Brian, Professor and Chair of Biochemistry, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo • conversation
Jan. 17, 2023 ~8 min


Will omicron-specific booster shots be more effective at combating COVID-19? 5 questions answered

The FDA’s authorization of the reformulated COVID-19 booster shots represents a major step in the effort to get more Americans boosted.

Mitzi Nagarkatti, Professor of Pathology, Microbiology and Immunology, University of South Carolina • conversation
Sept. 1, 2022 ~9 min

Will omicron-specific booster shots be effective at combating COVID-19? 5 questions answered

The FDA’s authorization of the reformulated COVID-19 booster shots represents a major step in the effort to get more Americans boosted.

Mitzi Nagarkatti, Professor of Pathology, Microbiology and Immunology, University of South Carolina • conversation
Sept. 1, 2022 ~9 min

Should you get a COVID-19 booster shot now or wait until fall? Two immunologists help weigh the options

On the horizon: A new omicron-focused version of the Moderna vaccine that may offer longer protection and a stronger immune response.

Mitzi Nagarkatti, Professor of Pathology, Microbiology and Immunology, University of South Carolina • conversation
June 27, 2022 ~8 min

How can scientists update coronavirus vaccines for omicron? A microbiologist answers 5 questions about how Moderna and Pfizer could rapidly adjust mRNA vaccines

The new omicron variant of coronavirus has a number of mutations that may require manufacturers to update vaccines. The unique attributes of mRNA vaccines make updating them fast and easy.

Deborah Fuller, Professor of Microbiology, School of Medicine, University of Washington • conversation
Dec. 2, 2021 ~8 min

Why Moderna won't share rights to the COVID-19 vaccine with the government that paid for its development

Moderna claims its scientists alone invented the mRNA sequence used to produce its COVID-19 vaccine. The US government, which helped fund the drug, disagrees.

Ana Santos Rutschman, Assistant Professor of Law, Saint Louis University • conversation
Nov. 18, 2021 ~11 min

An infectious disease expert explains new federal rules on 'mix-and-match' vaccine booster shots

As boosters are authorized for all three COVID-19 shots available in the US, the ability to swap out vaccine types looks to be a boon to the immune system.

Glenn J. Rapsinski, Pediatric Infectious Diseases Fellow, University of Pittsburgh Health Sciences • conversation
Oct. 22, 2021 ~9 min


Should fully immunized people wear masks indoors? An infectious disease physician weighs in

As Los Angeles County again mandates masking indoors -- even for the fully vaccinated -- local health officials in the U.S. are closely eyeing their own COVID-19 vaccination and infection rates.

Peter Chin-Hong, Associate Dean for Regional Campuses, University of California, San Francisco • conversation
July 22, 2021 ~9 min

Kids aren't just littler adults – here's why they need their own clinical trials for a COVID-19 vaccine

As many teens and adults in the US restart their social lives, parents of children under the age of 12 wonder when their kids will also be able to experience the freedom that comes with vaccination.

Judy Martin, Professor of Pediatrics, University of Pittsburgh • conversation
July 16, 2021 ~10 min

/

3